Gentian Diagnostics AS (OSL:GENT) COGS-to-Revenue : 0.36 (As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Gentian Diagnostics AS COGS-to-Revenue?

Gentian Diagnostics AS's Cost of Goods Sold for the three months ended in Mar. 2025 was kr16.1 Mil. Its Revenue for the three months ended in Mar. 2025 was kr44.5 Mil.

Gentian Diagnostics AS's COGS to Revenue for the three months ended in Mar. 2025 was 0.36.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Gentian Diagnostics AS's Gross Margin % for the three months ended in Mar. 2025 was 63.76%.

Gentian Diagnostics AS COGS-to-Revenue Historical Data

The historical data trend for Gentian Diagnostics AS's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gentian Diagnostics AS COGS-to-Revenue Chart

Gentian Diagnostics AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

COGS-to-Revenue

Get a 7-Day Free Trial

0.51

0.52

0.46

Gentian Diagnostics AS Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
COGS-to-Revenue	Get a 7-Day Free Trial															0.47	0.43	0.48	0.44	0.36

Gentian Diagnostics AS COGS-to-Revenue Calculation

Gentian Diagnostics AS's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	69.254	/	152.07
	=	0.46

Gentian Diagnostics AS's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	16.125	/	44.501
	=	0.36

Gentian Diagnostics AS (OSL:GENT) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Gentian Diagnostics AS's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	16.125 / 44.501
	=	63.76 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Gentian Diagnostics AS COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Gentian Diagnostics AS's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Gentian Diagnostics AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gentian Diagnostics AS (OSL:GENT) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

GENTOo:Sweden 6FK:Germany

Address

Bjornasveien 5, Moss, NOR, 1596

Website

https://www.gentian.com

Gentian Diagnostics AS operates as a medical diagnostics company in Norway. It develops and produces in-vitro diagnostic reagents (IVD) for use in medical diagnostics and research. Its portfolio and pipeline of reagents span areas of inflammations, severe infections, kidney diseases, heart failures, and veterinary healthcare. The company's product portfolio includes the Gentian Cystatin C Immunoassay, the GCAL circulating calprotectin immunoassay (IVDR), the Gentian Retinol Binding Protein (RBP), and the Gentian Canine CRP among others. Geographically, it generates a majority of its revenue from Europe followed by Asia and the United States of America.